JAGGAER is the world’s largest independent spend management company, with over 2,000 customers connected to a network of four million suppliers in 70 countries. JAGGAER offers complete SaaS-based Source to Pay eProcurement solutions and intelligent workflow capabilities all on a single platform, JAGGAER ONE. JAGGAER has pioneered spend solutions for over two decades and continues to lead the innovation curve by listening to customers and stakeholders in all industry sectors, public services and academia.
The healthcare business of LexisNexis Risk Solutions has mastered the art of combining, analyzing and delivering data and analytics to optimize quality, performance, and impact across health care entities. Our solutions leverage the industry’s most robust and accurate provider data, comprehensive public records, proprietary linking and claims analytics, predictive science, and computing platform to transform the business of healthcare.
ZAGENO is on a mission to accelerate scientific innovation by streamlining biotech purchasing for research and development through its award-winning enterprise marketplace. With over 19 million products available from more than 3,500 suppliers, ZAGENO makes online shopping for any research material convenient, efficient, and reliable. Available on desktop, tablet, and mobile devices, ZAGENO makes biotech purchases easier than ever and is an ideal sales channel for suppliers. Founded in 2015, ZAGENO operates in the United States, the United Kingdom, and Germany.
MolPort was created in 2006 to help scientists accelerate drug discovery by handling the ordering process of screening compounds and building blocks. Our goal is to help scientists focus on their research, not on procurement. Compound sourcing is a very specific job that requires very specialized expertise and software tools. MolPort specializes in sourcing hundreds or thousands of compounds from dozens of suppliers. MolPort can help you to procure compounds and prepare them for use. Here is how:
- Consolidate shipments from multiple suppliers into one shipment
- Sample reformatting according to your requirements
- Quality control tests at an independent laboratory
- Custom Synthesis sourcing of individual compounds and libraries
TrialCard’s RxStudy Card™ utilizes the North American pharmacy network to provide subjects with un-blinded prescription and OTC medication, as well as ancillary supplies for clinical trials. RxStudy Card™ provides logistic and financial efficiencies for clinical supplies, allowing faster and easier study start up, flexibility, affordability, and improved management of subject safety and adherence. For more information, please visit www.trialcard.com
BenchSci uses artificial intelligence to optimize reagent procurement and experimental success. Backed by Google’s AI fund, Gradient Ventures, BenchSci uses machine learning to diagnose R&D health from hidden patterns in procurement data. Customers receive a report on failure rates, productivity, and redundancy by department, therapeutic area, geography, and cost center. They can then address inefficiencies by deploying BenchSci's AI-Assisted Reagent Selection, which empowers scientists to select the best reagents and design criteria for their experiments. A turnkey application of AI with immediate, quantifiable impact, and proven ROI BenchSci now optimizes reagent procurement and experimental success in 15 of the top 20 pharmaceutical companies and over 3,600 leading academic centers globally.
ENGIE North America Inc. offers a range of capabilities in the United States and Canada to help customers decarbonize, decentralize and digitalize their operations. These include comprehensive services to help customers run their facilities more efficiently and optimize energy and other resource use and expense; clean power generation; energy storage; and retail energy supply that includes renewable, demand response, and on-bill financing options. Nearly 100% of the company’s power generation portfolio is low carbon or renewable.
As novel cell and gene therapies continue to expand, you need a solution that can manage the complete product development process from discovery and development through pre-clinical and clinical research, through post-market safety monitoring. WellSky Biotherapies allows you to build workflows and manufacturing procedures to effectively manage autologous and allogeneic protocols. It expands your ability to centralize and share data through a single system while decreasing batch review, approval, and release times, accelerating understanding of therapeutic outcomes.
Learn more at wellsky.com
Scientist.com is the world's largest enterprise marketplace for outsourced R&D services. The marketplace simplifies the entire research sourcing process, saving time and money while maintaining full compliance with an organization’s procurement policies. The marketplace features 3,000+ registered suppliers offering over 4,000 research areas across multiple industries. Scientist.com operates private enterprise marketplaces for most of the world’s top 25 major pharmaceutical companies, more than 40 biotechnology companies and the US National Institutes of Health (NIH).